Covered recipient · General Payments record
KATHRYNE L BUEGE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$413.05
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $186.04 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $39.44 | 2 |
| GlaxoSmithKline, LLC. | $30.88 | 2 |
| Amneal Pharmaceuticals LLC | $25.75 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $23.66 | 1 |
| Phathom Pharmaceuticals, Inc. | $18.21 | 1 |
| Lundbeck LLC | $18.17 | 1 |
| Novo Nordisk AS | $15.14 | 1 |
| SHIELD THERAPEUTICS INC | $14.79 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.62 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103387163 | CMS |
| ABBVIE INC. | $20.82 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103387165 | CMS |
| Amneal Pharmaceuticals LLC | $25.75 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139181511 | CMS |
| Boston Scientific Corporation | $23.66 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092307442 | CMS |
| GlaxoSmithKline, LLC. | $15.99 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116144417 | CMS |
| GlaxoSmithKline, LLC. | $14.89 | 12/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116240574 | CMS |
| Lundbeck LLC | $18.17 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145901266 | CMS |
| Novo Nordisk Inc | $15.14 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096666281 | CMS |
| Phathom Pharmaceuticals, Inc. | $18.21 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151044394 | CMS |
| SHIELD THERAPEUTICS INC | $14.79 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150149773 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.